Medici Brands

Medici Brands announced $250M in Series B financing on September 2, 2026. Medici Brands raised a $250 million Series B co-led by Greenoaks and Valor Equity Partners to expand David Protein and HallPass and launch new brands.

Round details

The financing includes backing from Greenoaks, Valor Equity Partners, ICONIQ, Imaginary Ventures, Peter Rahal. The company did not publish a valuation with the announcement.

• Round: Series B
• Capital announced: $250M

How the company plans to use the capital

Medici said the new capital will accelerate its next phase of growth, including expanding HallPass’ retail presence and product portfolio and extending David into new formats and categories. It will also fund product innovation and the infrastructure needed to launch and scale new brands such as Rowdy.

Why this matters for GTM teams

Greenoaks and Valor Equity Partners, which both invested in David’s $75 million Series A in 2025, co-led the round, and the statements from both firms quoted in the release refer to Medici’s technology.

Fresh capital is often an operational signal rather than a buying signal by itself. Teams should validate the company’s hiring pattern, product launches, geographic expansion, and technology priorities before choosing the message and timing of outreach.

Source and methodology

This report is based on the company’s announcement and records the disclosed amount, round, investors, location, and stated use of funds. SalesTools Research does not estimate undisclosed valuation or revenue figures.

Primary source: Medici Brands Series B announcement.